Find activities

8 results

  • Feedback on proposal to amend access criteria for type 2 diabetes medicines

    We sought your feedback on a proposal for people living with Type 2 diabetes and at risk of cardio-renal complications. We are proposing to widen access to: empagliflozin (Jardiance) empagliflozin with metformin (Jardiamet) dulaglutide (Trulicity) liraglutide (Victoza) More
    Closed 11 June 2026

  • Proposal for the supply of dapsone tablets

    The current brand of dapsone 25 and 50 mg tablets is being discontinued. We have sourced another brand but it is only available as 50 mg and 100 mg tablets. Let us know how this change might affect you or people you know. More
    Opened 9 June 2026

  • Review of the Exceptional Circumstances Framework

    Pharmac is reviewing its Exceptional Circumstances Framework (the Framework) after people told us it needs to work better and is hard to understand. The Framework includes the Named Patient Pharmaceutical Assessment (NPPA) policy and other ways Pharmac can fund medicines for individuals in special or exceptional clinical situations. The Discussion Document You can read the full text of the ' Review of the Exceptional Circumstances Framework... More
    Closed 7 June 2026

  • Operational Policy and Procedures Manual review

    We are updating our Operating Policies and Procedures Manual (the Manual) to bring it into line with the breadth of Pharmac’s current practices and the current health system. It was last updated in 2017. Downloads Proposed 2026 Manual [PDF, 597KB] Current 2017 Manual [PDF, 596KB] More
    Closed 26 May 2026

  • Proposal to enter into an agreement for a range of medical devices supplied by Smith & Nephew

    Pharmac is seeking feedback on a proposal to enter into an agreement for a range of medical devices supplied by Smith & Nephew Limited (“Smith & Nephew”) in Part III of Section H of the Pharmaceutical Schedule from 1 July 2026 in the following categories: surgical implants medical and surgical instruments and power tools Consultation closes at 4pm, Monday 25 May 2026 and feedback can be emailed to mikka.nocete@pharmac.govt.nz ... More
    Closed 25 May 2026

  • Proposal for new supply agreements for funded vaccines in the National Immunisation Schedule, and widened access to influenza vaccine

    We are entering new supply arrangements for some funded vaccines. These changes will: guarantee continued supply of 17 funded vaccines and a diagnostic test widen access to a flu vaccine for children (from 6 months until their 5th birthday) widen access to pneumoccal vaccine for people who have had a serious pneumoccal infection. More
    Opened 21 May 2026

  • Possible brand changes through Pharmac's annual tender

    We are seeking feedback on possible brand changes for medicines in Pharmac’s annual tender. More
    Closed 4 May 2026

  • Joint proposal from Pharmac and Health New Zealand to expand pharmacy services

    Health New Zealand is proposing to expand funding for a range of services and treatments that pharmacists can provide directly to defined groups of patients with common conditions including: treatment for scabies oral rehydration for children pain and fever management for children treatment of headlice treatment for conjunctivitis for children treatment for urinary tract infections the emergency... More
    Closed 30 April 2026
8 results. Page 1 of 1